80 related articles for article (PubMed ID: 24832033)
21. Cortical and brainstem LTP-like plasticity in Huntington's disease.
Crupi D; Ghilardi MF; Mosiello C; Di Rocco A; Quartarone A; Battaglia F
Brain Res Bull; 2008 Jan; 75(1):107-14. PubMed ID: 18158103
[TBL] [Abstract][Full Text] [Related]
22. "Ectopic" theta oscillations and interictal activity during slow-wave state in the R6/1 mouse model of Huntington's disease.
Pignatelli M; Lebreton F; Cho YH; Leinekugel X
Neurobiol Dis; 2012 Dec; 48(3):409-17. PubMed ID: 22842017
[TBL] [Abstract][Full Text] [Related]
23. Development of biomarkers for Huntington's disease.
Weir DW; Sturrock A; Leavitt BR
Lancet Neurol; 2011 Jun; 10(6):573-90. PubMed ID: 21601164
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease.
Lefaucheur JP; Bachoud-Levi AC; Bourdet C; Grandmougin T; Hantraye P; Cesaro P; Degos JD; Peschanski M; Lisovoski F
Mov Disord; 2002 Nov; 17(6):1294-301. PubMed ID: 12465071
[TBL] [Abstract][Full Text] [Related]
25. Altered ventral striatal activation during reward and punishment processing in premanifest Huntington's disease: a functional magnetic resonance study.
Enzi B; Edel MA; Lissek S; Peters S; Hoffmann R; Nicolas V; Tegenthoff M; Juckel G; Saft C
Exp Neurol; 2012 May; 235(1):256-64. PubMed ID: 22366326
[TBL] [Abstract][Full Text] [Related]
26. Huntington's disease: alterations of visual and somatosensory cortical evoked potentials in patients and offspring.
Oepen G; Doerr M; Thoden U
Adv Neurol; 1982; 32():141-7. PubMed ID: 6459718
[TBL] [Abstract][Full Text] [Related]
27. Abnormal intracortical facilitation in early-stage Huntington's disease.
Nardone R; Lochner P; Marth R; Ausserer H; Bratti A; Tezzon F
Clin Neurophysiol; 2007 May; 118(5):1149-54. PubMed ID: 17336146
[TBL] [Abstract][Full Text] [Related]
28. Noninvasive brain stimulation in Huntington's disease.
Berardelli A; Suppa A
Handb Clin Neurol; 2013; 116():555-60. PubMed ID: 24112923
[TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis of Huntington's disease: what the clinician should know.
Cardoso F
Neurodegener Dis Manag; 2014; 4(1):67-72. PubMed ID: 24640980
[TBL] [Abstract][Full Text] [Related]
30. Mentalizing in preclinical Huntington's disease: an fMRI study using cartoon picture stories.
Saft C; Lissek S; Hoffmann R; Nicolas V; Tegenthoff M; Juckel G; Brüne M
Brain Imaging Behav; 2013 Jun; 7(2):154-62. PubMed ID: 23179063
[TBL] [Abstract][Full Text] [Related]
31. Visual (VEP) and somatosensory (SSEP) evoked potentials in Huntington's chorea.
Oepen G; Doerr M; Thoden U
Electroencephalogr Clin Neurophysiol; 1981 Jun; 51(6):666-70. PubMed ID: 6165568
[TBL] [Abstract][Full Text] [Related]
32. Early modifications of auditory event-related potentials in carriers of the Huntington's disease gene.
de Tommaso M; Sciruicchio V; Specchio N; Difruscolo O; Vitale C; Specchio LM; Puca F
Acta Neurol Belg; 2003 Dec; 103(4):192-8. PubMed ID: 15008503
[TBL] [Abstract][Full Text] [Related]
33. Cortical myoclonus in Huntington's disease.
Thompson PD; Bhatia KP; Brown P; Davis MB; Pires M; Quinn NP; Luthert P; Honovar M; O'Brien MD; Marsden CD
Mov Disord; 1994 Nov; 9(6):633-41. PubMed ID: 7845404
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease.
Bohanna I; Georgiou-Karistianis N; Hannan AJ; Egan GF
Brain Res Rev; 2008 Jun; 58(1):209-25. PubMed ID: 18486229
[TBL] [Abstract][Full Text] [Related]
35. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794
[TBL] [Abstract][Full Text] [Related]
36. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
[TBL] [Abstract][Full Text] [Related]
37. Error processing in Huntington's disease.
Beste C; Saft C; Andrich J; Gold R; Falkenstein M
PLoS One; 2006 Dec; 1(1):e86. PubMed ID: 17183717
[TBL] [Abstract][Full Text] [Related]
38. Postexcitatory inhibition after transcranial magnetic single and double brain stimulation in Huntington's disease.
Tegenthoff M; Vorgerd M; Juskowiak F; Roos V; Malin JP
Electroencephalogr Clin Neurophysiol; 1996 Aug; 101(4):298-303. PubMed ID: 8761039
[TBL] [Abstract][Full Text] [Related]
39. EEG characteristics in juvenile Huntington's disease: a case report and review of the literature.
Landau ME; Cannard KR
Epileptic Disord; 2003 Sep; 5(3):145-8. PubMed ID: 14684349
[TBL] [Abstract][Full Text] [Related]
40. Cortical Myoclonus in Huntington's disease associated with an enlarged somatosensory evoked potential.
Caviness JN; Kurth M
Mov Disord; 1997 Nov; 12(6):1046-51. PubMed ID: 9399235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
